| Literature DB >> 33604755 |
Zeynep Nas1, Helena M S Zavos2, Athula Sumathipala3,4, Kaushalya Jayaweera3, Sisira Siribaddana5, Matthew Hotopf6,7, Frühling V Rijsdijk8.
Abstract
Anxiety not only concerns mental wellbeing but also negatively impacts other areas of health. Yet, there is limited research on (a) the genetic and environmental aetiology of such relationships; (b) sex differences in aetiology and (c) non-European samples. In this study, we investigated the genetic and environmental variation and covariation of anxiety symptoms and eight components of health-related quality of life (QoL), as measured by the short form health survey (SF-36), using genetic twin model fitting analysis. Data was drawn from the Colombo Twin and Singleton Study (COTASS), a population-based sample in Sri Lanka with data on twins (N = 2921) and singletons (N = 1027). Individual differences in anxiety and QoL traits showed more shared environmental (family) effects in women. Men did not show familial effects. Anxiety negatively correlated with all eight components of QoL, mostly driven by overlapping unique (individual-specific) environmental effects in both sexes and overlapping shared environmental effects in women. This is the first study in a South Asian population supporting the association between poor mental health and reduced QoL, highlighting the value of integrated healthcare services. Associations were largely environmental, on both individual and family levels, which could be informative for therapy and intervention.Entities:
Keywords: Anxiety; Non-western samples; Quality of life; Sex differences; Twin study
Mesh:
Year: 2021 PMID: 33604755 PMCID: PMC8225527 DOI: 10.1007/s10519-021-10051-1
Source DB: PubMed Journal: Behav Genet ISSN: 0001-8244 Impact factor: 2.805
Number of individuals included in the analyses, by sex and zygosity group
| Zygosity | Males | Females | Total number of individuals |
|---|---|---|---|
| MZ | |||
| Number of individual twins in full pairsa | 478 | 668 | 1263 |
| Number of single twins | 55 | 62 | |
| DZ | |||
| Number of individual twins in full pairsa | 302 | 410 | 850 |
| Number of single twins | 63 | 75 | |
| DZOS | |||
| Number of individual twins in full pairsa | 343 | 343 | 808 |
| Number of single twins | 47 | 75 | |
| Singletons | 388 | 639 | 1027 |
| Total | 1676 | 2272 | 3948 |
MZ monozygotic twins, DZ dizygotic twins, DZOS dizygotic opposite sex twins
aThese are individuals who are part of a complete twin pair
Means (SD) of Age, Anxiety symptoms & health related quality of life (QoL) measures
| MZM | DZM | MZF | DZF | DZOS | Singleton males | Singleton females | |
|---|---|---|---|---|---|---|---|
| Age | 37.53 (12.49) | 39.41 (13.02) | 39.21 (12.83) | 43.09 (14.07) | 40.28 (13.19) | 52.48 (15.45) | 50.84 (14.32) |
| Anxiety | 1.53 (2.75) | 1.29 (2.62) | 1.90 (3.06) | 2.01 (3.78) | 1.83 (3.30) | 1.85 (3.48) | 2.36 (3.75) |
| General health | 63.26 (14.97) | 62.83 (14.39) | 61.45 (16.35) | 60.28 (16.94) | 61.01 (15.88) | 60.94 (15.04) | 57.14 (17.71) |
| Physical functioning | 93.82 (14.90) | 93.95 (13.36) | 88.53 (19.25) | 88.05 (19.24) | 91.39 (17.06) | 87.12 (22.62) | 82.94 (21.53) |
| Role of physical problems | 86.11 (31.72) | 88.67 (29.47) | 81.97 (35.3) | 79.24 (37.01) | 82.21 (35.43) | 79.86 (38.02) | 78.21 (39.24) |
| Emotional wellbeing | 78.85 (15.70) | 80.5 (14.00) | 77.36 (15.58) | 76.83 (16.78) | 78.57 (15.94) | 80.44 (14.15) | 76.25 (17.42) |
| Role of emotional problems | 88.7 (28.88) | 91.53 (25.10) | 85.24 (31.9) | 85.91 (31.89) | 87.39 (30.65) | 88.17 (30.31) | 84.56 (34.44) |
| Energy/fatigue | 74.3 (17.15) | 75.3 (14.97) | 74.56 (16.49) | 73.80 (17.07) | 74.21 (16.83) | 71.16 (16.83) | 69.63 (17.68) |
| Pain | 88.7 (19.57) | 90.3 (16.99) | 85.46 (20.78) | 83.56 (21.29) | 86.34 (19.52) | 87.64 (20.46) | 86.50 (21.10) |
| Social functioning | 89.93 (17.81) | 91.31 (17.76) | 88.5 (19.05) | 88.31 (20.86) | 89.65 (18.56) | 89.22 (21.47) | 89.00 (20.48) |
The range of the anxiety scale = 0–21; The range of the total SF-36 sub-scales = 1–100
MZM monozygotic male twins, MZF monozygotic female twins, DZM dizygotic male twins, DZF dizygotic female twins, DZOS dizygotic opposite sex twins
Twin correlations (cross-twin within trait) (with 95% CIs)
| QoL variable | MZM | DZM | MZF | DZF | DZOS |
|---|---|---|---|---|---|
| Anxiety | .09 (− .07/.25) | .08 (− .12/.26) | .01 (− .08/.11) | ||
| General health | .11 (.00/.22) | ||||
| Physical functioning | .12 (− .13/.32) | ||||
| Role of physical problems | .05 (− .11/.20) | .20 (− .01/.37) | .02 (− .08/.12) | ||
| Emotional wellbeing | .18 (− .01/.35) | .10 (.00/.21) | |||
| Role of emotional problems | .09 (− .14/.30) | .05 (− .05/.16) | |||
| Energy/fatigue | |||||
| Pain | .11 (− .02/.24) | .05 (− .07/.16) | |||
| Social functioning |
Significant twin correlations are given in bold (as indicated by 95% CI not crossing zero). Please note that cross-twin cross trait correlations can be found in Supplementary Table 2
MZM monozygotic male twins, MZF monozygotic female twins, DZM dizygotic male twins, DZF dizygotic female twins, DZOS dizygotic opposite sex twins
Standardised variance components of Anxiety symptoms and health related quality of life (QoL) measures in males and females (with 95% CIs) obtained from univariate analyses
| QoL variable | Sex | Aetiology (95% CI) | ||
|---|---|---|---|---|
| Anxiety | M | .09 (.00/.24) | .00 (.00/.09) | |
| F | .00 (.00/.21) | |||
| General health | M | .17 (.00/.36) | .10 (.00/.29) | |
| F | .04 (.00/.30) | |||
| Physical functioning (scalar model) | M | F | .16 (.00/.39) | .16 (.00/.33) | |
| Role of physical problems | M | .09 (.00/.23) | .00 (.00/.15) | |
| F | .00 (.00/.31) | .27 (.00/.35) | ||
| Emotional wellbeing (scalar model) | M | F | .04 (.00/.21) | ||
| Role of emotional problems | M | .17 (.00/.30) | .02 (.00/.16) | |
| F | .00 (.00/.16) | |||
| Energy/fatigue (scalar model) | M | F | .01 (.00/.26) | ||
| Pain (scalar model) | M | F | .00 (.00/.19) | .15 (.00/.21) | |
| Social functioning | M | .07 (.00/.23) | .00 (.00/.00) | |
| F | .02 (.00/.18) | |||
Significant parameters are given in bold (as indicated by 95% CI not crossing zero). These estimates are obtained from the univariate heterogeneity sex limitation analysis. Note that for three variables (physical functioning, emotional wellbeing, and pain) we fit models which specify same aetiology across sex, but allowing different variances. Also note that for the energy/fatigue variable, the homogeneity model fit best, meaning that the aetiology was equal across sex
M males, F females, A additive genetic influences, C common environmental influences, E unique environmental influences
Phenotypic correlations between anxiety symptoms and health related quality of life (QoL) measures with their corresponding A, C and E components (with 95% CIs) in males and females
| QoL variable | Sex | Phenotypic correlation (rPh) (95% CI) | rPh components (95% CI) | ||
|---|---|---|---|---|---|
| rPh-A | rPh-C | rPh-E | |||
| General health | M | − | − .01 (− .11/.09) | .00 (− .05/.03) | − |
| F | − | − .02 (− .10/.08) | − | − | |
| Physical functioning | M | − | − .11 (− .22/.05) | .00 (− .13/.04) | − |
| F | − | − .02 (− .18/.10) | − .08 (− .16/.06) | − | |
| Role of physical problems | M | − | − .05 (− .15/.05) | .00 (− .03/.04) | − |
| F | − | .00 (− .08/.10) | − | − | |
| Emotional wellbeing | M | − | − .05 (− .13/.01) | − .04 (− .11/.01) | − |
| F | − | − .07 (− .14/.00) | − | − | |
| Role of emotional problems | M | − | − .10 (− .20/.02) | .00 (− .08/.02) | − |
| F | − | .00 (− .12/.04) | − | − | |
| Energy/fatigue | M | − | − .08 (− .20/.03) | − .03 (− .14/.04) | − |
| F | − | .02 (− .16/.06) | − | − | |
| Pain | M | − | − .03 (− .13/.06) | − .04 (− .11/.02) | − |
| F | − | .01 (− .15/.07) | − .13 (− .19/.00) | − .15 (− .23/− .08) | |
| Social functioning | M | − | − .15 (− .26/.07) | − .01 (− .25/.02) | − |
| F | − | .06 (− .33/.06) | − .18 (− .30/.06) | − | |
Significant parameters given in bold, as indicated by 95% CI not crossing zero
M males, F females, rPh phenotypic correlation, rPh-A additive genetic component of rPh, rPh-C common environmental component of rPh, rPh-E Unique environmental component of rPh